Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1213/ANE.0000000000007296 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Neostigmine: Incompletely Understood and Perhaps Incorrectly Utilized.
Anesth Analg
January 2025
Department of Anesthesiology, University of Utah, Salt Lake City, Utah.
Parkinson's disease and comorbid myasthenia gravis: a case report and literature review.
Front Neurol
January 2024
Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Background: Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease. Myasthenia gravis (MG) is a rare autoimmune disease caused by antibodies against the neuromuscular junction. PD and comorbid MG are rarely seen.
View Article and Find Full Text PDFInternal carotid artery aneurysm with incomplete isolated oculomotor nerve palsy: a case report.
J Med Case Rep
February 2023
The Third People's Hospital of Hubei Province, Wuhan, Hubei, China.
Background: Oculomotor nerve palsy is a common and well-described disease with diverse etiologies. Clinicians should quickly and correctly diagnose and treat oculomotor nerve palsy according to its characteristics and the accompanying symptoms and signs. Intracranial aneurysm is an important and frequent cause of oculomotor nerve palsy.
View Article and Find Full Text PDFCase Report: Successful Reversal of Residual Block with Sugammadex in a Patient Not Known to Have Myasthenia Gravis.
Am J Case Rep
October 2022
Department of Anesthesiology, Cathay General Hospital, Taipei, Taiwan.
BACKGROUND Incomplete recovery from residual neuromuscular block agent (NMBA) after anesthesia is a serious adverse event in the post-anesthesia care unit. Acetylcholinesterase neostigmine is usually used to reverse residual neuromuscular blockade and facilitate spontaneous breathing and endotracheal extubation. CASE REPORT A 40-year-old woman received general anesthesia for strabismus correction surgery.
View Article and Find Full Text PDFBackground: Neuromuscular blocking (NMB) agents are often administered to facilitate tracheal intubation and prevent patient movement during surgical procedures requiring the use of general anesthetics. Incomplete reversal of NMB, can lead to residual NMB, which can increase the risk of post-operative pulmonary complications. Sugammadex is indicated to reverse neuromuscular blockade induced by rocuronium or vecuronium in adults.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!